Bittium Biosignals signs supply agreement with Boston Scientific for ECG devices

Bittium Biosignals, a subsidiary of Bittium Corporation, has signed an agreement with Boston Scientific Cardiac Diagnostics to supply electrocardiogram measuring devices for cardiac arrhythmia monitoring, valued at approximately USD 30-45 million, with revenues accruing during 2025-2028.

“The total value of the new agreement will be approximately USD 30–45 million, with revenues accruing during 2025–2028.”news.cision.com

• 1 source
• news.cision.comInside Information: Bittium Corporation's Subsidiary Bittium Biosignals Ltd. and Boston Scientific Have Signed an Agreement for the Supply of Electrocardiogram Monitoring Devices - Bittium OyjJun 4, 2025

Summarized from public sources; check the original articles before acting on it.